Michael Dördelmann

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 601 citations · Full text

Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Michael Dördelmann, Alfred Reiter, Arndt Borkhardt et al. · Blood · 1999 · 345 citations

Does Breastmilk Influence the Development of Bronchopulmonary Dysplasia?

Juliane Spiegler, Michael Preuß, Corinna Gebauer et al. · The Journal of Pediatrics · 2015 · 166 citations

Does Breastmilk Influence, Lactation, Pediatrics +3

Immaturity, perinatal inflammation, and retinopathy of prematurity: A multi-hit hypothesis

Olaf Dammann, Maria-Jantje Brinkhaus, Dorothee B. Bartels et al. · Early Human Development · 2009 · 135 citations

Ocular Disease, Ophthalmology, Early Life Exposure +6

Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials

Michael Dördelmann, Martin Schrappe, Andreas Reiter et al. · Leukemia · 1998 · 118 citations

Down Syndrome, Hematological Malignancy, Treatment Outcome +6